Brigit Biofarmaka Teknologi Tbk. vs KDB Tifa Finance Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume), while KDB Tifa Finance Tbk. trades at Rp314 (market cap 1.13T, 52.4K 24h volume). The key difference: KDB Tifa Finance Tbk. is far larger — about 6.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and KDB Tifa Finance Tbk. is more actively traded (52.4K versus 50.3K). Which is the better fit depends on your goals.
| OBAT | TIFA | |
|---|---|---|
Market Cap | 164.65B | 1.13T |
Volume | 50.3K | 52.4K |
Lot | 503 | 524 |
Turnover | 12.13M | 16.34M |
Average Price | 241.18 | 311.86 |
Value | 12.13M | 16.34M |
Indicative Equilibrium Price | 238 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Tifa Finance Tbk (the company) was established under its original name of PT Tifa Mutual Finance Corporation base on notarial deed No.42 of Esther Daniar, S.H, dated on 14 Jun, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No. 1 of Fathiah Helmi, S.H., dated Aug 2, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on TIFA →